NO914056L - Fremgangsmaate for fremstilling av 5h-benzodiazepinderivat - Google Patents
Fremgangsmaate for fremstilling av 5h-benzodiazepinderivatInfo
- Publication number
- NO914056L NO914056L NO91914056A NO914056A NO914056L NO 914056 L NO914056 L NO 914056L NO 91914056 A NO91914056 A NO 91914056A NO 914056 A NO914056 A NO 914056A NO 914056 L NO914056 L NO 914056L
- Authority
- NO
- Norway
- Prior art keywords
- preparing
- procedure
- benzodiazepine derivatives
- benzodiazepine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/02—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
l-(3-klorfenyl)-4-hydroksymetyl- 7, 8-dimetoksy-5H-2,3-benzodiazepin med '. formel (I) ¿¿/.fe" og farmasøytisk akseptable syreaddi- sjonssalter derav. Forbindelsen og saltene har verdifulle angstdempende, antiaggresjons- og antidepresjons- virkninger, og har samtidig gunstige verdier med hensyn til akutt toksi- sitet. Fremstillingen av forbindelsen og saltene er beskrevet.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU906469A HU207055B (en) | 1990-10-17 | 1990-10-17 | Process for producing new 5h-2,3-benzodiazepine derivative and pharmaceutical compositions comprising same |
Publications (2)
Publication Number | Publication Date |
---|---|
NO914056D0 NO914056D0 (no) | 1991-10-16 |
NO914056L true NO914056L (no) | 1992-04-21 |
Family
ID=10971685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO91914056A NO914056L (no) | 1990-10-17 | 1991-10-16 | Fremgangsmaate for fremstilling av 5h-benzodiazepinderivat |
Country Status (28)
Country | Link |
---|---|
US (1) | US5204343A (no) |
JP (1) | JPH04282374A (no) |
KR (1) | KR920008011A (no) |
CN (1) | CN1033582C (no) |
AT (1) | AT399506B (no) |
AU (1) | AU648111B2 (no) |
BE (1) | BE1004995A3 (no) |
BG (1) | BG95336A (no) |
CA (1) | CA2053622A1 (no) |
CH (1) | CH682400A5 (no) |
CZ (1) | CZ282249B6 (no) |
DE (1) | DE4134402A1 (no) |
DK (1) | DK174891A (no) |
ES (1) | ES2036137B1 (no) |
FI (1) | FI914918A (no) |
FR (1) | FR2668148B1 (no) |
GB (1) | GB2248838B (no) |
GR (1) | GR1001068B (no) |
HU (1) | HU207055B (no) |
IL (1) | IL99637A (no) |
IT (1) | IT1256279B (no) |
NL (1) | NL9101741A (no) |
NO (1) | NO914056L (no) |
PL (1) | PL167108B1 (no) |
RU (1) | RU2058982C1 (no) |
SE (1) | SE506380C2 (no) |
YU (1) | YU47859B (no) |
ZA (1) | ZA918273B (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP9701284A3 (en) * | 1997-07-24 | 2005-11-28 | Egyt Gyogyszervegyeszeti Gyar | Use of 2,3-benzodiazepine derivatives for producing pharmaceutical compositions for treating and prophylacting illnesses and conditions connected with the endogene opioide system |
US6649607B2 (en) * | 2001-05-18 | 2003-11-18 | Vela Pharmaceuticals, Inc. | Compositions and methods for treating or preventing convulsions or seizures |
US7022700B2 (en) * | 2002-12-03 | 2006-04-04 | Vela Pharmaceuticals, Inc. | Method of increasing neutrophil production using optically-pure (R)-2,3-benzodiazepines |
CA2508542A1 (en) * | 2002-12-03 | 2004-06-17 | Vela Pharmaceuticals, Inc. | Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5h-2,3-benzodiazepine and uses thereof |
US6864251B2 (en) * | 2002-12-03 | 2005-03-08 | Vela Pharmaceuticals, Inc. | Treatment of LTB4-mediated inflammatory disorders with optically-pure (R)-2,3-benzodiazepines |
US6638928B1 (en) | 2002-12-03 | 2003-10-28 | Vela Pharmaceuticals, Inc. | Treatment of irritable bowel syndrome and nonulcer dyspepsia with substituted 2,3-benzodiazepines |
WO2004069155A2 (en) * | 2002-12-03 | 2004-08-19 | Vela Pharmaceuticals, Inc. | Pharmaceutical composition of 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5h-2,3-benzodiazepine and uses therof |
US20040162284A1 (en) * | 2003-02-19 | 2004-08-19 | Harris Herbert W. | Method of lowering body temperature with (S) tofisopam |
US20040224943A1 (en) * | 2003-02-19 | 2004-11-11 | Leventer Steven M. | Method of lowering body temperature with (R) - 2,3-benzodiazepines |
US20040254173A1 (en) * | 2003-06-13 | 2004-12-16 | Leventer Steven M. | Modulation of dopamine responses with substituted (S)-2,3-benzodiazepines |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2257274A1 (en) * | 1974-01-16 | 1975-08-08 | Synthelabo | Substd. 1,2-diazepin-7-one analgesic and psychotropic agents - prepd by cyclizing a delta keto acid and a substd hydrazine |
HU179018B (en) * | 1978-10-19 | 1982-08-28 | Gyogyszerkutato Intezet | Process for producing new 5h-2,3-benzodiazepine derivatives |
HU191698B (en) * | 1984-07-27 | 1987-03-30 | Gyogyszerkutato Intezet | Process for producing new 1-aryl-5h-2beta-benzodiazepines |
-
1990
- 1990-10-17 HU HU906469A patent/HU207055B/hu not_active IP Right Cessation
-
1991
- 1991-10-02 IL IL9963791A patent/IL99637A/en not_active IP Right Cessation
- 1991-10-15 KR KR1019910018098A patent/KR920008011A/ko not_active Application Discontinuation
- 1991-10-16 NO NO91914056A patent/NO914056L/no unknown
- 1991-10-16 RU SU915010047A patent/RU2058982C1/ru active
- 1991-10-16 CZ CS913141A patent/CZ282249B6/cs unknown
- 1991-10-16 DK DK174891A patent/DK174891A/da not_active Application Discontinuation
- 1991-10-17 GR GR910100426A patent/GR1001068B/el unknown
- 1991-10-17 CA CA002053622A patent/CA2053622A1/en not_active Abandoned
- 1991-10-17 AT AT0207191A patent/AT399506B/de not_active IP Right Cessation
- 1991-10-17 DE DE4134402A patent/DE4134402A1/de not_active Withdrawn
- 1991-10-17 FR FR9112807A patent/FR2668148B1/fr not_active Expired - Fee Related
- 1991-10-17 ES ES9102303A patent/ES2036137B1/es not_active Expired - Lifetime
- 1991-10-17 ZA ZA918273A patent/ZA918273B/xx unknown
- 1991-10-17 AU AU85922/91A patent/AU648111B2/en not_active Ceased
- 1991-10-17 CN CN91109753A patent/CN1033582C/zh not_active Expired - Fee Related
- 1991-10-17 BE BE9100952A patent/BE1004995A3/fr not_active IP Right Cessation
- 1991-10-17 US US07/776,771 patent/US5204343A/en not_active Expired - Fee Related
- 1991-10-17 GB GB9122090A patent/GB2248838B/en not_active Expired - Fee Related
- 1991-10-17 YU YU166991A patent/YU47859B/sh unknown
- 1991-10-17 CH CH3051/91A patent/CH682400A5/de not_active IP Right Cessation
- 1991-10-17 PL PL91292091A patent/PL167108B1/pl unknown
- 1991-10-17 IT ITMI912745A patent/IT1256279B/it active IP Right Grant
- 1991-10-17 SE SE9103022A patent/SE506380C2/sv not_active IP Right Cessation
- 1991-10-17 FI FI914918A patent/FI914918A/fi not_active Application Discontinuation
- 1991-10-17 NL NL9101741A patent/NL9101741A/nl not_active Application Discontinuation
- 1991-10-17 JP JP3298535A patent/JPH04282374A/ja active Pending
- 1991-10-17 BG BG095336A patent/BG95336A/bg unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY108885A (en) | Heterocyclic-cyclic amine derivatives. | |
ES8801789A1 (es) | Un procedimiento para la preparacion de derivados de indol | |
MX9701329A (es) | Metodos para la inhibicion de la replicacion viral. | |
NO914056L (no) | Fremgangsmaate for fremstilling av 5h-benzodiazepinderivat | |
NZ300942A (en) | 1-aryl-2-acylamino-ethane derivatives as neurokinin 1 antagonists | |
HK1001974A1 (en) | Pharmaceutical piperazine compounds | |
MX9709466A (es) | Medicamento para inhibir el melanoma. | |
AU693241B2 (en) | New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments | |
MX9701333A (es) | Metodos para inhibir el daño neuronal. | |
LTIP801A (en) | Tryciclic pyridone derivative | |
ATE200623T1 (de) | Verwendung von 2-phenyl-3-aroylbenzothiophen derivaten zur herstellung eines medikaments zur hemmung der primären endometriumhyperplasie | |
ES2063700A1 (es) | Agente activo sobre el sistema nervioso central, proceso para su preparacion y composiciones farmaceuticas que lo contengan. | |
MX9702853A (es) | Metodos para inhibir condiciones asociadas con el neuropeptido "y". | |
MX9702861A (es) | Metodo para inhibir las condiciones asociadas con la bradicinina. | |
SU1623143A1 (ru) | 1-бензил-6-метокси-3-метил-1н-1,2-диазафенален, обладающий гипотензивной активностью | |
MX9706072A (es) | Metodos de inhibicion de la adhesion celula-celula. | |
MX9803271A (es) | Uso de la 1-(2-naft-2-iletil)-4-(3-trifluorometilfenil)-1,2,6-tetrahid ropiridina para la preparacion de farmacos para el tratamiento de esclerosis lateral aminotrofica. | |
MX9705537A (es) | Metodos y composiciones para inhibir el efecto de los estrogenos del medio ambiente. |